Female Sexual Desire Drug Rejected by U.S. Regulators

A pill to treat low sexual desire in women was rejected by U.S. regulators, a decision that has been appealed by the drug’s maker in a bid to make it the first product for the disorder.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.